# Vtama in Psoriasis Patients Being Treated With Biologics.

> **NCT06103695** · PHASE4 · COMPLETED · sponsor: **Psoriasis Treatment Center of Central New Jersey** · enrollment: 30 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Tapinarof

## Key facts

- **NCT ID:** NCT06103695
- **Lead sponsor:** Psoriasis Treatment Center of Central New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06103695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06103695, "Vtama in Psoriasis Patients Being Treated With Biologics.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06103695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*